Literature DB >> 16441604

In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.

Donald M Arnold1, Nancy M Heddle, Myron Kulczycky, Julie Carruthers, Christopher Sigouin, Morris A Blajchman.   

Abstract

BACKGROUND: Methods of platelet preparation may alter the recovery and survival characteristics of platelets following transfusion. As suggested by a recent clinical trial, platelet recovery may be better preserved with apheresis platelet preparations than with platelets prepared from whole blood by the platelet-rich plasma (PRP) method. STUDY DESIGN AND METHODS: In vivo platelet recovery and survival of autologous leukoreduced (LR) apheresis platelets and autologous filter-LR PRP platelets were compared in 22 healthy volunteers using a paired crossover design. On the same day, each participant gave one apheresis platelet donation and one whole blood donation from which platelets were recovered from the PRP. The sequence of donations was randomly assigned for each participant. Following 5 days of storage and bacterial screening, a sample from each platelet product was labeled with either (51)chromium or (111)indium (randomly assigned) and both samples were simultaneously re-infused into the original donor. Recovery and gamma-function platelet survival were calculated for each platelet product using the multiple hit mathematical model.
RESULTS: Five day stored LR-apheresis platelets had 18.8 percent better recovery, and 32.9 percent longer gamma-survival than filter-LR PRP platelets. Stored apheresis platelets had lower p-selectin expression and higher morphology scores than stored PRP platelets.
CONCLUSIONS: Filter-LR PRP platelet preparation appears to adversely affect platelet recovery and survival characteristics. The reasons for this effect are not clear. These results may not apply to all apheresis and PRP methods of platelet preparation.

Entities:  

Mesh:

Year:  2006        PMID: 16441604     DOI: 10.1111/j.1537-2995.2006.00709.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences.

Authors:  Peter Hellstern
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

2.  2 Platelet Concentrates.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 3.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

Review 4.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Gemma L Crighton; Lise J Estcourt; Erica M Wood; Marialena Trivella; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

5.  Identification of platelet refractoriness in oncohematologic patients.

Authors:  Aline Aparecida Ferreira; Roberto Zulli; Sheila Soares; Vagner de Castro; Helio Moraes-Souza
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system.

Authors:  Sanne de Bruin; Emma K van de Weerdt; Davina Sijbrands; Richard Vlaar; Eric Gouwerok; Bart J Biemond; Alexander P J Vlaar; Robin van Bruggen; Dirk de Korte
Journal:  Transfusion       Date:  2019-07-18       Impact factor: 3.157

7.  A numerical analysis model for the interpretation of in vivo platelet consumption data.

Authors:  Ted S Strom
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.